SEC Tracker
Get the app

Orchestra BioMed Holdings OBIO

Orchestra BioMed Holdings raises $86.3M

Orchestra BioMed Holdings (OBIO) filed an 8-K with the SEC on Nov 9, 2026, 4:16 pm ET. Source: the filing on SEC EDGAR.

Item 1.01 Enters material agreement, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. 15,000,000 shares of common stock offered at $5.00 each
  2. Underwriters purchased 2,250,000 additional shares
  3. Proceeds to fund AVI Modulation Therapy and BACKBEAT trial
  4. Net proceeds to support Virtue SAB program and other initiatives

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Orchestra BioMed Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.